BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Other News

Icagen, Pfizer neurology news

Icagen shareholders Merlin Nexus and New Leaf Venture Partners filed a letter with the SEC contesting the planned acquisition by partner Pfizer of the 89% of Icagen it does not already own for $6 per share, or about...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >